Immunocytokines are a promising immunotherapeutic approach against glioblastoma-Reference-Cited by-同舟云学术

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

Published:2020-10-07 Issue:564 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Weiss Tobias¹^ORCID,Puca Emanuele²^ORCID,Silginer Manuela¹^ORCID,Hemmerle Teresa³^ORCID,Pazahr Shila⁴,Bink Andrea⁴^ORCID,Weller Michael¹^ORCID,Neri Dario²^ORCID,Roth Patrick¹^ORCID

Affiliation:

1. Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, CH-8091 Zurich, Switzerland.

2. Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Vladimir-Prelog-Weg 4, CH-8093 Zürich, Switzerland.

3. Philochem AG, CH-8112 Otelfingen, Switzerland.

4. Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, CH-8091 Zurich, Switzerland.

Abstract

Immunocytokines display promising antitumor activity in orthotopic mouse models of glioma and patients with glioblastoma.

Funder

European Research Council

Swiss National Science Foundation

Oncosuisse

Forschungskredit University of Zurich

Swiss Cancer Research Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference53 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

2. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

3. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: The CheckMate 143 phase 3 randomized clinical trial;Reardon D. A.;JAMA Oncol.,2020

4. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

5. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment;Current Opinion in Immunology;2024-02

2. AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus—A joint EAACI‐EANO position paper;Allergy;2024-01-24

3. Glioma–Immune Cell Crosstalk in Tumor Progression;Cancers;2024-01-11

4. Immunotherapy against gliomas;Der Nervenarzt;2024-01-02

5. Nanobodies in cytokine‑mediated immunotherapy and immunoimaging (Review);International Journal of Molecular Medicine;2023-12-06